Moderna COVID-19 Vaccine (Spikevax) from China
An mRNA vaccine targeting the spike protein of SARS-CoV-2 for prevention of COVID-19 in humans. Classified in HTS 3002.41.00.00 as a human vaccine product for prophylactic immunization.
Duty Rate — China → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Obtain FDA emergency use authorization documentation and import permit before shipment
• Label shipments clearly with biohazard warnings and maintain -70°C ultra-cold chain throughout import